TMDX FY 2019 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

FY 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+81.3% YoY

Gross Profit

$14M58.7% margin

Operating Income

-$30M-125.4% margin

Net Income

-$34M-142.1% margin

EPS (Diluted)

$-2.36

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$854,000

Balance Sheet

Total Assets

$105M

Total Liabilities

$51M

Stockholders' Equity

$55M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$13M	+81.3%
Gross Profit	$14M	$6M	+141.8%
Operating Income	-$30M	-$20M	-46.3%
Net Income	-$34M	-$24M	-41.2%